Google and pharmaceutical giant GSK spend $700 million to create a black technology company: will change the treatment model for chronic diseases

On August 1, 2016, Alps-based life sciences company Verily and pharmaceutical giant GlaxoSmithKline (GSK) will co-found a joint venture called Galvani Bioelectronics to benefit the majority of chronically ill patients. If Galvani Bioelectronics succeeds, a few years later it will either slow down the patient's dependence on drugs, and entrepreneurs no longer have to worry about taking drugs on time.

The newly formed joint venture is headquartered in the United Kingdom and is named Galvani Bioelectronics to commemorate the 18th century Italian scientist Galvani. Verily and GSK are committed to investing more than $700 million in the joint venture company Galvani Bioelectronics over the next seven years to develop bioelectronic medical devices for the treatment of chronic diseases. A 55% stake in the new company is held by GSK and Verily holds the remaining shares.

Google and pharmaceutical giant GSK spend $700 million to create a black technology company: will change the treatment model for chronic diseases

In 1780, Galvani discovered that the muscles of the dead frog's leg muscles would vibrate when they contacted the electric spark, becoming the first person to discover bioelectricity.

Electroceuticals is a relatively new field that aims to modify the electrical signals of the nervous system using small implantable devices, including irregular nerve impulses that occur in many diseases, including treatments like diabetes. , arthritis, chronic asthma, its therapeutic effect targets specific organs and there is no need to worry about side effects of drugs. This field has been very hot recently. At a scientific conference, researchers joked: "The small devices of bioelectronics medicine can bring peace to the world." In this emerging field, GSK has always been the leader in this field. In the past four years, GSK has invested a total of $50 million in its field.


Introduction video of bioelectronics medicine

Drug Testing Equipment

Nanjing Superyears Gene Technology Co., Ltd found in Sep.2017,focuses on the research and development of high-end life science instruments, integrating R&D, production, sales and maintenance. The core team members are all experts in the biomedical field, and it is a high-tech innovative enterprise with professional technical background. The company is a high-tech enterprise certified by the Ministry of science and technology,Drug Testing Equipment,Drugs Testing Equipment,Drug Rapid Test,Professional Multipanel Drugtest with more than 50 patents.

Drug Testing Equipment,Drugs Testing Equipment,Drug Rapid Test,Professional Multipanel Drugtest

Nanjing Superyears Gene Technology Co., Ltd. , https://www.superyearsglobal.com